ORGANIC
LETTERS
2006
Vol. 8, No. 17
3667-3670
Synthetic Studies toward the
Bryostatins: A Substrate-Controlled
Approach to the A-Ring
Gary E. Keck,* Dennie S. Welch, and Paige K. Vivian†
Department of Chemistry, UniVersity of Utah, 315 South 1400 East RM 2020,
Salt Lake City, Utah 84112-0850
Received May 12, 2006
ABSTRACT
The synthesis of a C1−C13 A-ring subunit of bryostatin 1 is detailed. The key features of the approach include the convergent fragment
assembly with a highly stereoselective construction of the C7−C8 bond indicated above.
Pettit and co-workers reported in 1982 the isolation and
structural identification of bryostatin 1 (1) from the bryozoan
Bugula neritina.1 Seventeen structurally related congeners
have since been isolated and identified, and the family
remains of significant interest to the biological, medical, and
synthetic communities.2 Bryostatin 1 exhibits an impressive
array of biological properties including anticancer activity,
synergistic anticancer activity with established therapeutic
agents such as vincristine,3 and activity against Alzheimer’s
disease.4 Bryostatin 1 is known to bind to PKCR with
nanomolar affinity, but this elicits different biological
responses than those associated with binding by the tumor-
promoting phorbol esters.5 The reasons for these differences
and the mechanisms by which bryostatin 1 affects the
aforementioned areas of therapeutic interest remain unclear.
In 1990, Masamune and co-workers disclosed the first total
synthesis of bryostatin 7.6 More recently, both the Evans7
and the Yamamura8 groups have reported bryostatin total
syntheses. In addition, the promising biological profile of
bryostatin 1, coupled with its scarcity from natural sources,
has encouraged a number of other synthetic efforts in this
area.9 Wender and co-workers have also reported on the
synthesis and biological studies of several analogues of
bryostatin 1.10
The synthetic strategy chosen for implementation is
detailed in Figure 1. Methodology developed in these
laboratories for the construction of 2,6-disubstituted-4-
methylene tetrahydropyrans9g,h,11 was envisioned to join an
A-ring hydroxy allylsilane 2 and a C-ring enal 3 with
concomitant formation of the B-ring. The A-ring containing
the necessary pendant allylsilane could be derived from
(6) Kageyama, M.; Tamura, T.; Nantz, M. H.; Roberts, J. C.; Somfai,
P.; Whritenour, D. C.; Masamune, S. J. Am. Chem. Soc. 1990, 112, 7407.
(7) Evans, D. A.; Carter, P. H.; Carreira, E. M.; Charette, A. B.; Prunet,
J. A.; Lautens, M. J. Am. Chem. Soc. 1999, 121, 7540.
(8) Ohmori, K.; Ogawa, Y.; Obitsu, T.; Ishikawa, Y.; Nishiyama, S.;
Yamamura, S. Angew. Chem., Int. Ed. 2000, 39, 2290.
(9) For recent synthetic work in this area, see: (a) Voight, E. A.; Seradj,
H.; Roethle, P. A.; Burke, S. D. Org. Lett. 2004, 6, 4045. (b) Voight, E.
A.; Roethle, P. A.; Burke, S. D. Org. Lett. 2004, 6, 4534. (c) Hale, K. J.;
Frigerio, M.; Manaviazar, S.; Hummersome, M. G.; Fillingham, I. J.;
Barsukov, I. G.; Damblon, C. F.; Gerscher, A.; Roberts, G. C. K. Org.
Lett. 2003, 5, 499. (d) Hale, K. J.; Frigerio, M.; Hummersome, M. G.;
Manaviazar, S. Org. Lett. 2003, 5, 503. (e) Ball, M.; Baron, A.; Bradshaw,
B.; Omori, H.; MacCormick, S.; Thomas, E. J. Tetrahedron Lett. 2004, 45,
8747. (f) Keck, G. E.; Yu, T.; McLaws, M. D. J. Org. Chem. 2005, 70,
2543. (g) Keck, G. E.; Truong, A. P. Org. Lett. 2005, 7, 2149. (h) Keck,
G. E.; Truong, A. P. Org. Lett. 2005, 7, 2153. (i) Ball, M.; Bradshaw, B.
J.; Dumeunier, R.; Gregson, T. J.; MacCormick, S.; Omori, H.; Thomas,
E. J. Tetrahedron Lett. 2006, 47, 2223.
† Undergraduate research participant.
(1) Pettit, G. R.; C. L.; Douobek, D. L.; Herald, D. L. J. Am. Chem.
Soc. 1982, 104, 6846.
(2) For reviews, see: (a) Hale, K. J.; Hummersome, M. G.; Manaviazar,
S.; Frigerio, M. Nat. Prod. Rep. 2002, 19, 413. (b) Mutter, R.; Wills, M.
Bioorg. Med. Chem. 2000, 8, 1841.
(3) Al-Katib, A. M.; Smith, M. R.; Kamanda, W. S.; Pettit, G. R.;
Hamdan, M.; Mohamed, A. N.; Chelladurai, B.; Mohammad, R. M. Clin.
Cancer Res. 1998, 4, 1305.
(4) Etcheberrigaray, R.; Tan, M.; Dewachter, I.; Kuiperi, C.; Van der
Auwera, I.; Wera, S.; Qiao, L.; Bank, B.; Nelson, T. J.; Kozikowski, A. P.;
Van Leuven, F.; Alkon, D. L. Proc. Natl. Acad. Sci., U.S.A. 2004, 101,
1141.
(5) Dell’Aquila, M. L.; Herald, C. L.; Kamano, Y.; Pettit, G. R.;
Blumberg, P. M. Cancer Res. 1988, 48, 3702.
10.1021/ol061173h CCC: $33.50
© 2006 American Chemical Society
Published on Web 07/20/2006